针对性抗体在血液循环过程中与药物输送脂质体分离
Unnur J Björgvinsdóttir1, Jannik B Larsen1, Martin Bak1
1Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark (DTU), Kgs. Lyngby, Denmark.
概括
在小鼠的血液循环过程中,向配合体从药物输送脂质体中脱离,阻碍了积极的向. 这种解离发生在体内,而不是体外,影响了新型药物递送系统的设计.
科学领域:
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
- 生物技术是生物技术.
背景情况:
- 活跃向脂质体对于药物输送至关重要,但面临临临床挑战.
- 现有的脂质体在循环过程中可能会失去准能力,从而限制治疗疗效.
研究的目的:
- 为了研究抗体基向配体与药物输送脂质体在小鼠循环过程中的解离.
- 为了确定体外方法是否准确地反映了体内连接体的稳定性.
主要方法:
- 带有DSPE-PEG定抗体连接体的脂质体在小鼠中循环了4小时.
- 脂质体表面的配体密度在循环后得到量化.
- 结合体稳定性在体内与体外 (血清化) 的比较.
主要成果:
- 很大一部分脂质体在循环后4小时内失去了所有向配体.
- 剩余的配体显示表面密度减少了>50%,无论抗体格式或链接化学.
- 结合体解离发生在体内,但在体外血清化过程中没有发生.
结论:
- 基于抗体的向配体在体内循环过程中与脂质体分离.
- 在体外测试对于评估脂质体向连接体稳定性是不够的.
- 这一发现对开发有效的向药物输送系统提出了关键挑战.
相关概念视频
Drug Distribution: Plasma Protein Binding
4.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
4.8K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
173
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
173
Factors Affecting Drug Distribution: Tissue Permeability
136
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
136
Factors Influencing Drug Absorption: Drug Dissolution
402
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
402
Drug Distribution: Tissue Binding
2.5K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.5K
Drug Binding to Blood Components
106
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
106


